We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
-$5.82B
Cap. Flow
+$1.91B
Cap. Flow %
4.16%
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$127M
2
CI icon
Cigna
CI
+$54M
3
CVS icon
CVS Health
CVS
+$38.8M
4
MPC icon
Marathon Petroleum
MPC
+$28.9M
5
FANG icon
Diamondback Energy
FANG
+$19M

Sector Composition

Rank Sector Weight
1 Technology 16.95%
2 Financials 15.85%
3 Healthcare 14.41%
4 Consumer Discretionary 10.13%
5 Industrials 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESS icon
251
Essex Property Trust
ESS
$18.3B
$33.4M 0.07%
136,232
+5,488
+4% +$1.38M
IDXX icon
252
Idexx Laboratories
IDXX
$44.1B
$33.4M 0.07%
179,418
-4,447
-2% -$912K
TFX icon
253
Teleflex
TFX
$6.05B
$33.3M 0.07%
128,957
+35,912
+39% +$9.09M
EIX icon
254
Edison International
EIX
$28.2B
$33.3M 0.07%
586,166
-1,417
-0.2% -$88.1K
WTW icon
255
Willis Towers Watson
WTW
$31.2B
$33.2M 0.07%
218,846
-2,119
-1% -$317K
VRSK icon
256
Verisk Analytics
VRSK
$25.4B
$33.1M 0.07%
303,520
-15,951
-5% -$1.86M
UAL icon
257
United Airlines
UAL
$39.4B
$33.1M 0.07%
394,959
-2,837
-0.7% -$249K
NOW icon
258
ServiceNow
NOW
$115B
$33M 0.07%
926,010
-23,685
-2% -$841K
MNST icon
259
Monster Beverage
MNST
$94.3B
$32.9M 0.07%
1,338,390
-91,166
-6% -$2.48M
RCL icon
260
Royal Caribbean
RCL
$85.1B
$32.9M 0.07%
336,322
-12,697
-4% -$1.39M
TSN icon
261
Tyson Foods
TSN
$20.4B
$32.7M 0.07%
613,273
-20,436
-3% -$1.2M
AEE icon
262
Ameren
AEE
$30.3B
$32.7M 0.07%
500,855
+23,011
+5% +$1.53M
VRSN icon
263
VeriSign
VRSN
$26.2B
$31.9M 0.07%
214,967
-10,206
-5% -$1.53M
CERN
264
DELISTED
Cerner Corp
CERN
$31.7M 0.07%
603,791
-17,776
-3% -$1.03M
BXP icon
265
Boston Properties
BXP
$11.2B
$31.4M 0.07%
278,992
+1,002
+0.4% +$121K
LHX icon
266
L3Harris
LHX
$51.6B
$30.9M 0.07%
229,499
-2,662
-1% -$402K
CHD icon
267
Church & Dwight Co
CHD
$23.4B
$30.8M 0.07%
468,497
-8,193
-2% -$519K
CTAS icon
268
Cintas
CTAS
$81.9B
$30.7M 0.07%
730,940
-30,616
-4% -$1.37M
OMC icon
269
Omnicom Group
OMC
$21.6B
$30.6M 0.07%
418,382
-15,515
-4% -$1.15M
FAST icon
270
Fastenal
FAST
$54.7B
$30.3M 0.07%
2,318,176
-49,948
-2% -$676K
INFO
271
DELISTED
IHS Markit Ltd. Common Shares
INFO
$29.9M 0.07%
623,804
+13,792
+2% +$705K
TDG icon
272
TransDigm Group
TDG
$70.2B
$29.8M 0.06%
87,653
-1,684
-2% -$578K
NTRS icon
273
Northern Trust
NTRS
$33.3B
$29.7M 0.06%
355,756
-3,292
-0.9% -$309K
EVRG icon
274
Evergy
EVRG
$19.1B
$29.7M 0.06%
523,289
+15,793
+3% +$912K
ABMD
275
DELISTED
Abiomed Inc
ABMD
$29.6M 0.06%
91,020
+520
+0.6% +$181K

Similar funds

RhumbLine Advisers's Q4 2018 Portfolio in Review

As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.

  • RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
  • RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
  • RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
  • RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
  • RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
  • RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.